Actelion provides details on restructuring effort
13:53 EDT 12 Jul 2012 | BioCentury
Actelion Ltd. (SIX:ATLN) said it will cut up to 135 positions, or about 5% of its approximately 2,500 employees, as part of a plan announced in May to reduce spending by refocusing R&D activities on specialty areas. The cuts will affect R&D and admin..
Original Article: Actelion provides details on restructuring effort
More From BioPortfolio on "Actelion provides details on restructuring effort"
Biotech & Healthcare Channels
World News
Life Science Events
Corporate Database
Market Reports
Categories
Search BioPortfolio:
